Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

NCT06786299

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: No. 79, Qingchun Road, Hangzhou City, Zhejiang Province. Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

NCT06783478

Conditions: Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hospital de Clinicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Not Yet Recruiting

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Avapritinib Maintenance for AML With KIT Mutations

NCT06765915

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT

NCT06765928

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

NCT06763666

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

NCT06702098

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Guangzhou Ruixin Biotechnology Co., Ltd Guangzhou, Guangdong Province, China, China

View Trial Details

Not Yet Recruiting

A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia

NCT06672263

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

Henan Cancer Hospital Zhengzhou, Henan, China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06652685

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

NCT06641648

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions